论文信息 - Optimal oncologic management and mTOR inhibitor introduction are safe and improve survival in kidney and liver allograft recipients with de novo carcinoma - 字舞流文

Optimal oncologic management and mTOR inhibitor introduction are safe and improve survival in kidney and liver allograft recipients with de novo carcinoma

C. Tournigand | L. Salomon | A. De la taille | C. Haioun | P. Wolkenstein | C. Tlemsani | C. Duvoux | P. Grimbert | C. Neuzillet | A. Laurent | J. Dupuis | D. Azoulay | P. Compagnon | M. Matignon | B. Rousseau | I. Cholley | Aude Guillemin | C. Salloum